Skip to content
Nonprofiteer
← UNITED STATES PHARMACOPEIAL CONVENTION INC

Form 990 for tax year 2023

Filed by UNITED STATES PHARMACOPEIAL CONVENTION INC.

Totals

Total revenue
$353,749,327
Total expenses
$330,337,653
Contributions and grants received
$31,691,692
Grants paid
$498,078
Program service revenue
$311,282,673
Investment income
$10,536,524
Other revenue
$238,438
Total assets, end of year
$750,835,911
Total liabilities, end of year
$188,101,832
Net assets or fund balances, end of year
$562,734,079
Program services expenses (Part IX)
$233,632,396
Management and general expenses
$95,873,129
Fundraising expenses
$832,128
Program service expenses (Part III)
$233,632,396

Program services were 70.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1e · Government grants (contributions)

    $30,192,067

  • 1f · All other contributions, gifts and grants

    $1,499,625

  • 1g · Noncash contributions included above

    $1,499,625

  • 2a · Program service revenue: COMPENDIAL ACTIVITIES

    total $302,557,090 · related or exempt $302,557,090

  • 2b · Program service revenue: ALLIED COMPENDIAL ACT.

    total $4,829,177 · related or exempt $4,829,177

  • 2c · Program service revenue: NON-COMPENDIAL ACT.

    total $3,896,406 · related or exempt $3,896,406

  • 3 · Investment income

    total $9,832,826 · excluded $9,832,826

  • 5 · Royalties

    total $228,620 · excluded $228,620

  • 7a · Gross sales of assets other than inventory

    securities $445,471,947

  • 7b · Less cost or other basis and sales expenses

    securities $444,440,201 · other assets $328,048

  • 7c · Gain or loss

    securities $1,031,746 · other assets -$328,048

  • 7d · Net gain or loss

    total $703,698 · excluded $703,698

  • 11a · Other revenue: MISCELLANEOUS REVENUE

    total $9,818 · excluded $9,818

  • 11e · Other revenue, total

    $9,818

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $300,191 · program services $300,191

  • 2 · Grants to domestic individuals

    total $35,000 · program services $35,000

  • 3 · Grants to foreign organizations and individuals

    total $162,887 · program services $162,887

  • 5 · Compensation of officers, directors and key employees

    total $5,557,610 · program services $2,496,164 · management and general $2,941,141 · fundraising $120,305

  • 7 · Other salaries and wages

    total $137,323,819 · program services $100,912,196 · management and general $35,977,834 · fundraising $433,789

  • 8 · Pension plan contributions

    total $13,302,037 · program services $9,627,156 · management and general $3,623,295 · fundraising $51,586

  • 9 · Other employee benefits

    total $11,666,797 · program services $8,443,675 · management and general $3,177,878 · fundraising $45,244

  • 10 · Payroll taxes

    total $9,508,544 · program services $6,881,671 · management and general $2,589,999 · fundraising $36,874

  • 11b · Fees: legal

    total $366,168 · management and general $366,168

  • 11c · Fees: accounting

    total $332,463 · management and general $332,463

  • 11d · Fees: lobbying

    total $222,178 · management and general $222,178

  • 11f · Fees: investment management

    total $953,687 · management and general $953,687

  • 11g · Fees: other

    total $32,852,614 · program services $22,514,143 · management and general $10,228,569 · fundraising $109,902

  • 12 · Advertising and promotion

    total $667,935 · program services $665,404 · management and general $2,531

  • 13 · Office expenses

    total $8,786,535 · program services $5,414,475 · management and general $3,372,060

  • 14 · Information technology

    total $16,067,888 · program services $3,064,022 · management and general $13,003,866

  • 16 · Occupancy

    total $7,016,993 · program services $2,122,998 · management and general $4,893,995

  • 17 · Travel

    total $4,607,711 · program services $4,009,280 · management and general $567,300 · fundraising $31,131

  • 19 · Conferences, conventions and meetings

    total $3,468,035 · program services $3,106,502 · management and general $361,157 · fundraising $376

  • 20 · Interest

    total $3,067,795 · management and general $3,067,795

  • 21 · Payments to affiliates

    total $36,327,862 · program services $34,203,658 · management and general $2,123,860 · fundraising $344

  • 22 · Depreciation, depletion and amortization

    total $9,936,188 · program services $4,790,580 · management and general $5,145,608

  • 23 · Insurance

    total $1,176,379 · management and general $1,176,379

  • 24a · Other expenses: COST OF GOODS SOLD

    total $16,973,621 · program services $16,973,621

  • 24b · Other expenses: VALIDATION &CALIBRATION

    total $3,427,888 · program services $3,236,220 · management and general $191,668

  • 24c · Other expenses: PUB/SUBSCRIPTIONS

    total $2,217,755 · program services $2,145,922 · management and general $71,428 · fundraising $405

  • 24d · Other expenses: EXHIBITS

    total $282,571 · program services $252,423 · management and general $30,148

  • 24e · All other expenses

    total $3,728,502 · program services $2,274,208 · management and general $1,452,122 · fundraising $2,172

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $26,386,133 · end of year $28,514,480

  • 2 · Savings and temporary cash investments

    beginning of year $29,791,627 · end of year $31,131,585

  • 3 · Pledges and grants receivable

    beginning of year $5,771,450 · end of year $7,154,593

  • 4 · Accounts receivable

    beginning of year $42,283,399 · end of year $48,602,810

  • 8 · Inventories for sale or use

    beginning of year $65,915,852 · end of year $69,203,646

  • 9 · Prepaid expenses and deferred charges

    beginning of year $11,594,049 · end of year $12,988,689

  • 10a · Land, buildings and equipment: cost or other basis

    $248,720,473

  • 10b · Land, buildings and equipment: accumulated depreciation

    $122,619,400

  • 10c · Land, buildings and equipment, net

    beginning of year $130,462,715 · end of year $126,101,073

  • 11 · Investments: publicly traded securities

    beginning of year $268,930,059 · end of year $291,583,862

  • 12 · Investments: other securities

    beginning of year $65,322,012 · end of year $77,660,533

  • 15 · Other assets

    beginning of year $55,311,136 · end of year $57,894,640

  • 17 · Accounts payable and accrued expenses

    beginning of year $66,136,200 · end of year $69,885,754

  • 19 · Deferred revenue

    beginning of year $6,411,400 · end of year $7,404,393

  • 20 · Tax-exempt bond liabilities

    beginning of year $91,861,224 · end of year $87,329,897

  • 25 · Other liabilities

    beginning of year $26,464,396 · end of year $23,481,788

  • 27 · Net assets without donor restrictions

    beginning of year $510,895,212 · end of year $562,734,079

Mission and programs · 2023

Mission

USP'S MISSION IS TO IMPROVE GLOBAL HEALTH THROUGH PUBLIC STANDARDS AND RELATED PROGRAMS THAT HELP ENSURE THE QUALITY, SAFETY, AND BENEFIT OF MEDICINES AND FOODS.

Activities or mission (Part I)

TO IMPROVE THE HEALTH OF PEOPLE AROUND THE WORLD THROUGH PUBLIC STANDARDS AND (SEE SCHEDULE O) RELATED PROGRAMS THAT HELP ENSURE THE QUALITY, SAFETY, AND BENEFIT OF MEDICINES AND FOODS.

  • COMPENDIAL ACTIVITIES - SEE SCHEDULE O

    Expenses $190,619,517 · Revenue $302,557,090

  • ALLIED COMPENDIAL ACTIVITIES - SEE SCHEDULE O

    Expenses $6,692,932 · Grants $498,078 · Revenue $4,829,177

  • NON-COMPENDIAL ACTIVITIES - SEE SCHEDULE O

    Expenses $36,319,947 · Revenue $3,896,406

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Dennis E Doherty MD

    CONVENTION PRESIDENT

    Total calculated
    $0
    Hours/week
    4
  • Todd K Abraham PhD MBA

    TREASURER

    Total calculated
    $0
    Hours/week
    4
  • Gregory E Amidon PhD

    PHARMACEUTICAL SCIENCES TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Gwen Darien

    PUBLIC TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Richard J Gilfillan MD MBA

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Jesse L Goodman MD MPH

    MEDICAL SCIENCES TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Laura Herman MBA Ma

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Thomas Menighan Bspharmmba

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Krishna Reddy Nallamalla MD

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Stephen Ostroff MD

    MEDICAL SCIENCES TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Julio Sanchez Y Tepoz Mscsjd

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • John Taylor JD

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Susan Winckler Rph JD

    CHAIR AND PHARMA SCI TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Ronald T Piervincenzi

    CHIEF EXECUTIVE OFFICER & EX-OFFICIO

    Total calculated
    $1,155,162
    From this org
    $1,021,625
    From related orgs
    $0
    Other
    $133,537
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $737,453
    Bonus
    $259,430
    Other
    $24,742
    Deferred
    $122,538
    Nontaxable benefits
    $10,999
    Filer's total
    $1,155,162
  • Anthony P Lakavage

    SECRETARY & SVP GLBL EA

    Total calculated
    $588,677
    From this org
    $509,150
    From related orgs
    $0
    Other
    $79,527
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $385,781
    Bonus
    $97,702
    Other
    $25,667
    Deferred
    $70,955
    Nontaxable benefits
    $8,572
    Filer's total
    $588,677
  • Amanda D Cowley

    SVP LEGAL PEOPLE STRATEGY

    Total calculated
    $582,355
    From this org
    $508,482
    From related orgs
    $0
    Other
    $73,873
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $385,425
    Bonus
    $98,747
    Other
    $24,310
    Deferred
    $63,676
    Nontaxable benefits
    $10,197
    Filer's total
    $582,355
  • Jakob Venema

    EVP & CHIEF SCIENCE OFFICER

    Total calculated
    $702,694
    From this org
    $609,378
    From related orgs
    $0
    Other
    $93,316
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $465,577
    Bonus
    $117,979
    Other
    $25,822
    Deferred
    $81,307
    Nontaxable benefits
    $12,009
    Filer's total
    $702,694
  • Stanley D Burhans

    CHIEF FINANCIAL OFFICER & SVP, OPS

    Total calculated
    $557,763
    From this org
    $480,371
    From related orgs
    $0
    Other
    $77,392
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $370,647
    Bonus
    $84,057
    Other
    $25,667
    Deferred
    $65,418
    Nontaxable benefits
    $11,974
    Filer's total
    $557,763
  • Jennifer Devine

    SVP, DOC STDS & COMP POLICY

    Total calculated
    $440,230
    From this org
    $408,257
    From related orgs
    $0
    Other
    $31,973
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $328,765
    Bonus
    $77,170
    Other
    $2,322
    Deferred
    $31,901
    Nontaxable benefits
    $72
    Filer's total
    $440,230
  • Bruk Alemayehu

    SVP, GLOBAL LAB & TECHNICAL OPS

    Total calculated
    $460,550
    From this org
    $412,396
    From related orgs
    $0
    Other
    $48,154
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $327,823
    Bonus
    $80,164
    Other
    $4,409
    Deferred
    $36,180
    Nontaxable benefits
    $11,974
    Filer's total
    $460,550
  • Venkat Surendra Nath Koduru

    SVP REGIONS & PROGRAM OPS.

    Total calculated
    $515,846
    From this org
    $485,652
    From related orgs
    $0
    Other
    $30,194
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $389,051
    Bonus
    $92,537
    Other
    $4,064
    Deferred
    $27,000
    Nontaxable benefits
    $3,194
    Filer's total
    $515,846
  • Emily M Kaine

    SVP, GBL HEALTH & MANUFACTURING SVCS

    Total calculated
    $554,335
    From this org
    $507,279
    From related orgs
    $0
    Other
    $47,056
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $407,767
    Bonus
    $97,702
    Other
    $1,810
    Deferred
    $40,684
    Nontaxable benefits
    $6,372
    Filer's total
    $554,335
  • Fouad Atouf

    SVP, SCI-GLOB BIO

    Total calculated
    $466,063
    From this org
    $414,734
    From related orgs
    $0
    Other
    $51,329
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $329,684
    Bonus
    $81,883
    Other
    $3,167
    Deferred
    $35,645
    Nontaxable benefits
    $15,684
    Filer's total
    $466,063
  • Michael S Levy

    SVP, DIGITAL & INNOVATION

    Total calculated
    $426,049
    From this org
    $382,355
    From related orgs
    $0
    Other
    $43,694
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $306,355
    Bonus
    $74,129
    Other
    $1,871
    Deferred
    $35,834
    Nontaxable benefits
    $7,860
    Filer's total
    $426,049
  • Kenneth B Alexander - Vp Dep

    GC (TO 10/23);VP MNG ATY GLB LG AFF

    Total calculated
    $372,160
    From this org
    $348,091
    From related orgs
    $0
    Other
    $24,069
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $277,152
    Bonus
    $59,780
    Other
    $11,159
    Deferred
    $17,528
    Nontaxable benefits
    $6,541
    Filer's total
    $372,160
  • Debra J Perez

    CHIEF EQUITY OFFICER

    Total calculated
    $455,443
    From this org
    $411,456
    From related orgs
    $0
    Other
    $43,987
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $324,828
    Bonus
    $74,564
    Other
    $12,064
    Deferred
    $38,000
    Nontaxable benefits
    $5,987
    Filer's total
    $455,443
  • Nurisha R Wade - Vp Hqs Coe

    (TO 12/23); VP, INDUSTRY PROGRAMS

    Total calculated
    $383,792
    From this org
    $347,977
    From related orgs
    $0
    Other
    $35,815
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $253,418
    Bonus
    $72,749
    Other
    $21,810
    Deferred
    $32,986
    Nontaxable benefits
    $2,829
    Filer's total
    $383,792

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4b · Supplemental nonqualified retirement plan
  • 7 · Other non-fixed payments

Answered no

  • 4a · Severance or change-of-control payment
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

SCHEDULE J, PART I, LINE 4B:
SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN DURING THE YEAR, CERTAIN INDIVIDUALS PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. NONE OF THE INDIVIDUALS LISTED ON SCHEDULE J, PART II RECEIVED TAXABLE PAYMENTS IN THE CURRENT YEAR. THE FOLLOWING INDIVIDUALS RECEIVED DEFERRED CONTRIBUTIONS (UNPAID AND ELIGIBLE FOR PAYMENT BASED ON VESTING AND PAYOUT SCHEDULE) REPORTED ON SCHEDULE J, PART II, COLUMN C, RETIREMENT AND OTHER DEFERRED COMPENSATION: RONALD T. PIERVINCENZI: $70,038 JAKOB VENEMA: $28,807 AMANDA D. COWLEY: $18,676 ANTHONY LAKAVAGE: $18,455 EMILY M. KAINE: $18,184 STANLEY D. BURHANS: $15,918 VENKAT SURENDRA NATH KODURU: $15,478 FOUAD ATOUF: $9,725 BRUK ALEMAYEHU: $8,996 JENNIFER DEVINE: $7,601 MICHAEL S. LEVY: $5,834 KENNETH B. ALEXANDER : $2,022 NURISHA R. WADE : $2,000
SCHEDULE J, PART I, LINE 7:
NON-FIXED PAYMENTS USP PROVIDES INCENTIVE COMPENSATION THAT IS COMMENSURATE WITH THE ACCOMPLISHMENT OF STATED GOALS. EACH INDIVIDUAL OFFICER, KEY EMPLOYEE, OR HIGHLY COMPENSATED EMPLOYEE HAS AN ANNUAL GOAL PLAN. BASED ON THE ACCOMPLISHMENT OF THOSE INDIVIDUAL STATED GOALS, THE INDIVIDUAL IS ELIGIBLE FOR A BONUS WHICH IS WITHIN A FIXED PERCENTAGE RANGE. BONUSES ARE CONSIDERED AS PART OF THE TOTAL COMPENSATION WHEN DETERMINING REASONABLENESS.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
14
Employees, agents and contractors (line 3c)
453
Expenditures and investments (line 3c)
$59,930,416

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Region Offices Employees Activity Specific services Expenditures
SOUTH AMERICA 1 9 PROGRAM SERVICES COMPENDIAL $2,325,846
EAST ASIA AND THE PACIFIC 1 20 PROGRAM SERVICES COMPENDIAL $4,497,158
SOUTH ASIA 1 320 PROGRAM SERVICES COMPENDIAL $18,196,311
SUB-SAHARAN AFRICA 1 19 PROGRAM SERVICES COMPENDIAL $2,044,371
EUROPE (INCLUDING ICELAND & GREENLAND) 1 6 PROGRAM SERVICES SALES OFFICE $2,774,009
SOUTH ASIA 1 3 PROGRAM SERVICES PQM OFFICE/USAID $482,909
EAST ASIA AND THE PACIFIC 1 4 PROGRAM SERVICES SALES OFFICE $1,145,613
SUB-SAHARAN AFRICA 5 39 PROGRAM SERVICES PQM OFFICE/USAID $3,036,468
EAST ASIA AND THE PACIFIC 1 16 PROGRAM SERVICES PQM OFFICE/USAID $724,536
SOUTH ASIA 1 17 PROGRAM SERVICES PQM OFFICE/USAID $741,435
SUB-SAHARAN AFRICA — — INVESTMENTS — $908,880
EAST ASIA AND THE PACIFIC — — INVESTMENTS — $3,509,608
EUROPE (INCLUDING ICELAND & GREENLAND) — — INVESTMENTS — $1,364,948
SOUTH AMERICA — — INVESTMENTS — $2,444,312
SOUTH ASIA — — INVESTMENTS — $15,571,125
EUROPE (INCLUDING ICELAND & GREENLAND) — — GRANTMAKING — $148,287
SOUTH AMERICA — — GRANTMAKING — $600
EAST ASIA AND THE PACIFIC — — GRANTMAKING — $14,000

Grants to organizations, by region (Part II)

The purpose of each grant is not shown.

Region Cash grants Manner of disbursement Noncash assistance Noncash description Valuation
EAST ASIA AND THE PACIFIC $14,000 WIRE TRANSFER $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $8,000 WIRE TRANSFER $0 — —
Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
—
Other grantees (Part II line 3)
2

Grants to individuals, by region (Part III)

The type of assistance is not shown.

Region Recipients Cash grants Manner of disbursement Noncash assistance
EUROPE (INCLUDING ICELAND & GREENLAND) 1 $140,287 WIRE TRANSFER —
Transferred property to a foreign corporation during the year (line 1)
Yes
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
Yes
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
Yes

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Disregarded entities

Part I: entities that legally are the filer and file no return of their own.

  • USP HOLDING LLC

    HOLDING · MD · income $36,831,369 · assets $21,475,888

    Directly controlled by USP

  • USP HOLDING INTERNATIONAL LLC

    HOLDING · MD · income $0 · assets $0

    Directly controlled by USP

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

  • US PHARMACOPEIA NIGERIA LTDGTE

    C · SCIENTIFIC · NI · 100% owned · share of income $689,043 · share of assets $903,342 · controlled entity

    Directly controlled by USPC

  • US PHARMACOPEIA PHILIPPINES INC

    C · SCIENTIFIC · RP · 100% owned · controlled entity

    Directly controlled by USPC

  • UNITED STATES FARMACOPEIA BRASIL LTDA

    C · SCIENTIFIC · BR · 100% owned · share of income $2,335,074 · share of assets $2,956,158 · controlled entity

    Directly controlled by USPHUSPHI

  • US PHARMACOPEIA STND RESEARCH & DEV

    C · SCIENTIFIC · CH · 100% owned · share of income $4,797,912 · share of assets $3,135,659 · controlled entity

    Directly controlled by USP HOLDING

  • US PHARMACOPEIA INDIA PRIVATE LTD

    C · SCIENTIFIC · IN · 100% owned · share of income $20,237,974 · share of assets $22,355,279 · controlled entity

    Directly controlled by USPHUSPHI

  • US PHARMACOPEIA-SINGAPORE PTELTD

    C · SCIENTIFIC · SN · 100% owned · share of income $1,199,008 · share of assets $1,218,962 · controlled entity

    Directly controlled by USP HOLDING

  • US PHARMACOPEIA SWITZERLAND AG

    C · SCIENTIFIC · SZ · 100% owned · share of income $3,026,241 · share of assets $4,550,786 · controlled entity

    Directly controlled by USP HOLDING

  • USP KENYA

    C · SCIENTIFIC · KE · 100% owned · share of income $1,178,956 · share of assets $428,078 · controlled entity

    Directly controlled by USP HOLDING

  • PHARMATECH ASSOCIATES INC

    C · SCIENTIFIC · CA · 100% owned · share of income $4,776,550 · share of assets $635,272 · controlled entity

    Directly controlled by USP HOLDING

Provenance

Return type
form_990
Tax year
2023
Filed
14 November 2024
IRS schema version
2023v5.1
Source object
202403199349304765

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.